These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18466159)

  • 1. Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factor.
    Cadwell CM; Zimring JC
    Vox Sang; 2008 Aug; 95(2):159-62. PubMed ID: 18466159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies.
    Nordling C; Holmdahl R; Klareskog L
    J Immunol; 1991 Jun; 146(12):4258-63. PubMed ID: 1710245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes.
    Zimring JC; Cadwell CM; Chadwick TE; Spitalnik SL; Schirmer DA; Wu T; Parkos CA; Hillyer CD
    Blood; 2007 Sep; 110(6):2201-8. PubMed ID: 17569819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor.
    Holmdahl R; Nordling C; Rubin K; Tarkowski A; Klareskog L
    Scand J Immunol; 1986 Aug; 24(2):197-203. PubMed ID: 3489283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
    Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
    Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5.
    Gach JS; Quendler H; Strobach S; Katinger H; Kunert R
    Mol Immunol; 2008 Feb; 45(4):1027-34. PubMed ID: 17804071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced red blood cell destruction by antibody fragments.
    Mqadmi A; Abramowitz S; Zheng X; Yazdanbakhsh K
    Immunohematology; 2006; 22(1):11-4. PubMed ID: 16563046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epibodies.
    Bona C
    Autoimmunity; 1989; 5(1-2):1-2. PubMed ID: 2485093
    [No Abstract]   [Full Text] [Related]  

  • 9. Complexes with anti-epitope tag IgGs improve the therapeutic potential of epitope-tagged antibody fragments.
    Xie X; Weisser NE; McLean MD; Hall JC
    Mol Immunol; 2010 Apr; 47(7-8):1529-34. PubMed ID: 20153529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies: better knowledge for a better use].
    Abès R; Dutertre CA; Teillaud JL
    Med Sci (Paris); 2009 Dec; 25(12):1011-9. PubMed ID: 20035672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhemolytic antibody-induced loss of erythrocyte surface antigen.
    Zimring JC; Hair GA; Chadwick TE; Deshpande SS; Anderson KM; Hillyer CD; Roback JD
    Blood; 2005 Aug; 106(3):1105-12. PubMed ID: 15831698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-antibody and other antiglobulin specificities in nonrheumatoid and rheumatoid effusion fluids and matched sera.
    Seward CW; Parker LP; Osterland CK
    J Lab Clin Med; 1974 Jan; 83(1):104-11. PubMed ID: 4543438
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen loss from antibody-coated red blood cells.
    Zimring JC; Cadwell CM; Spitalnik SL
    Transfus Med Rev; 2009 Jul; 23(3):189-204. PubMed ID: 19539874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Fab-fragments of antibodies against spleen cell surface antigens on the development of antibody formation in cultures of different densities].
    Korukova AA; Kim AB; Grigor'eva OS; Gurvich AE
    Biull Eksp Biol Med; 1984 Mar; 97(3):315-7. PubMed ID: 6704524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of murine and humanized chimaeric monoclonal antibodies for red cell phenotyping.
    Lee E; Burgess G; Halverson GR; Huang TJ; Reid ME
    Br J Haematol; 2004 Jul; 126(2):277-81. PubMed ID: 15238151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross-reactive rheumatoid factors and possibility of the therapeutic use of anti-idiotypes].
    Williams R
    Ter Arkh; 1981; 53(7):12-4. PubMed ID: 6170127
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report: atypical presentation of anti-Rg(a).
    Kahwash E; Talwalkar SS; Leonard J; Lockwood W
    Ann Clin Lab Sci; 2005; 35(1):100-4. PubMed ID: 15830717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid factor and its related anti-IgG antibodies: the present state and perspective].
    Ota T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):319-29. PubMed ID: 16583739
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
    Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
    Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.